Key result
High preoperative comorbidity linked to ~11-fold higher hospital mortality after shoulder arthroplasty.
Why the study?
The effect of preoperative comorbidity status defined by the Deyo index on outcomes and costs in shoulder arthroplasty patients was not well characterized.
Does a higher Deyo score predict worse outcomes and higher costs in shoulder arthroplasty patients?
Population
Shoulder arthroplasty patients
Comparison
Higher Deyo scores vs Deyo score 0
Design
Observational study using multiple regression analyses
Follow-up
In-hospital
Authors
Loading...
May aid preoperative risk stratification in shoulder arthroplasty; leaves open whether comorbidity optimization reduces mortality.
Observational
Does a higher Deyo score predict worse outcomes and higher costs in shoulder arthroplasty patients?
Odds Ratio: 11.8
p-value: p=0.011
Higher preoperative comorbidity status, as measured by the Deyo score, is strongly associated with increased hospital mortality, length of stay, and costs in shoulder arthroplasty patients.
Humphries et al. (2008) conducted an observational in Shoulder arthroplasty. High preoperative comorbidity status (Deyo score 5-36) vs. Deyo score = 0 was evaluated on Hospital mortality (adjusted OR 11.8, p=0.011). High preoperative comorbidity (Deyo score 5-36) in shoulder arthroplasty patients was associated with increased hospital mortality compared to a score of 0 (adjusted OR 11.8; p=0.011).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: